There is currently no way to permanently eliminate herpes from your body. Once herpes simplex virus (HSV-1 or HSV-2) infects you, it hides inside nerve cells in a dormant state that your immune system and existing medications cannot reach. That’s the straightforward answer, and it’s unlikely to change in the next few years. But the full picture is more nuanced than that, and more hopeful, than most people realize. Gene-editing research has already removed up to 97% of latent herpes DNA in animal models, antiviral options are improving, and for many people the virus becomes a manageable, minor part of life.
Why Herpes Can’t Be Cured Yet
After the initial infection, HSV travels along nerve fibers and settles into clusters of nerve cells called ganglia near the base of the skull (for oral herpes) or the lower spine (for genital herpes). Once there, the virus essentially shuts itself down. It stops replicating, stops producing viral proteins, and produces no infectious particles. Your immune system works by detecting foreign proteins on the surface of infected cells, so a virus that isn’t making any proteins is effectively invisible.
The virus achieves this through a clever bit of molecular camouflage. Its active genes get wrapped in tightly packed structures that keep them silenced, similar to how your own cells lock away genes they don’t need. Meanwhile, the virus produces small RNA molecules that keep the nerve cell alive and prevent it from self-destructing. These RNA molecules don’t trigger an immune response because they aren’t proteins. The result is a stable, long-term hiding spot where the virus can sit indefinitely, occasionally reactivating to produce new virus particles before going quiet again.
This is fundamentally different from infections your body can clear on its own, like the flu. Antiviral medications like valacyclovir work by blocking the virus from copying itself during active episodes, but they have no effect on dormant virus sitting silently in your neurons. It’s the biological equivalent of trying to shut down a factory that’s already closed.
Gene Editing: The Closest Thing to a Cure
Researchers at Fred Hutchinson Cancer Center have developed what may eventually become a true cure: using gene-editing enzymes to physically cut apart dormant HSV DNA inside nerve cells. Rather than waiting for the virus to wake up and then blocking it, this approach goes into the neurons and destroys the viral blueprint directly.
In mouse studies, this method eliminated 90% or more of latent HSV-1 DNA in models of oral infection, and up to 97% in models of genital infection. The delivery system uses harmless viruses (called AAV vectors) that are already used in approved gene therapies for other conditions. Researchers have been refining the approach to improve safety, using lower doses and neuron-specific targeting to reduce the chance of off-target effects.
A small human trial has already taken place, though not for typical herpes. Three patients with severe, treatment-resistant herpes eye disease received a gene-editing treatment. Over 18 months of follow-up, no off-target damage or serious side effects were detected, and the virus did not relapse. This is a very early result in a very specific group of patients, but it’s the first evidence that the concept works in people.
For the average person with oral or genital herpes, a gene-editing cure is likely still years away from clinical availability. Larger human trials are needed to confirm safety and efficacy across different populations. But this is no longer a theoretical idea. It’s an active, funded research program with animal proof-of-concept and early human data.
Vaccines in Development
No vaccine currently prevents or treats herpes, but several candidates are in clinical trials. Moderna completed a Phase 1/2 trial of an mRNA-based therapeutic vaccine (mRNA-1608) for people already infected with HSV-2. The goal of a therapeutic vaccine isn’t to eliminate the virus but to train the immune system to suppress reactivation more effectively, potentially reducing outbreaks and shedding without daily medication. Results from that trial have not yet been published in full, so it’s too early to say how well it works.
Therapeutic vaccines are a different goal from a cure. If successful, they would function more like a long-lasting treatment than an eradication, but they could be a significant upgrade over taking a daily pill indefinitely.
What Actually Works Right Now
Daily suppressive antiviral therapy is the most effective tool currently available. Taking valacyclovir every day reduces outbreak frequency by 70% to 80% in people with frequent recurrences, according to CDC treatment guidelines. It also decreases the rate of transmitting HSV-2 to an uninfected sexual partner.
A newer class of antiviral, represented by pritelivir, works through a completely different mechanism than valacyclovir and appears to be substantially more effective. In a Phase 2 clinical trial, people taking pritelivir had viral shedding detected on only 2.4% of days, compared to 5.3% on valacyclovir. That’s a 58% reduction in shedding. Genital lesions were present on 1.9% of days with pritelivir versus 3.9% with valacyclovir, roughly cutting outbreak days in half compared to the current standard. Pritelivir is not yet widely available but is approved in some contexts for immunocompromised patients.
Reducing Transmission Risk
Most herpes transmission happens when the virus is shedding without causing any visible symptoms. HSV-2 sheds on roughly 18% of days, averaging about 30 short shedding episodes per year. Approximately 80% of that shedding is asymptomatic, meaning there are no sores or warning signs. This is why herpes spreads as effectively as it does, and why relying on avoiding sex during outbreaks alone is not a reliable prevention strategy.
Consistent condom use reduces the risk of acquiring HSV-2 by about 30%, with no difference in protection between men and women. That’s a meaningful but moderate benefit. Combining condoms with daily suppressive antivirals provides a stronger layer of protection. Neither method eliminates risk entirely, but together they substantially lower it.
Supplements and Alternative Approaches
L-lysine is the most commonly discussed natural supplement for herpes prevention. The evidence for it is weak. A Cochrane review found only one randomized controlled trial worth including, and it rated the evidence as “very low” quality. Doses under 1 gram per day appear to be ineffective. One small trial suggested doses above 3 grams per day might reduce recurrence rates, but the study was too small to draw firm conclusions. If you want to try lysine, doses under 1 gram daily are unlikely to do anything, and the evidence for higher doses is preliminary at best.
Other commonly promoted remedies, including essential oils, monolaurin, and red marine algae, lack the clinical trial data to support their use for herpes suppression. They are not harmful in most cases, but there’s no reliable evidence they reduce outbreaks or shedding.
Testing and Knowing Your Status
If you’re unsure whether you have herpes, standard blood tests (IgG antibody tests) can detect past infection, but they come with an important caveat. Results with an index value between 1.1 and 3.0 have a high rate of false positives. Per CDC guidelines, any result in that range should be confirmed with a second, different test. One study found that 56% of samples with index values under 3.0 that were flagged as positive turned out to be false positives on confirmatory testing. If you’ve received a low-positive result and have never had symptoms, confirmatory testing is worth pursuing before making assumptions about your status.
Living With Herpes in Practical Terms
For most people, herpes becomes less disruptive over time. Outbreaks tend to decrease in frequency and severity in the years following initial infection, particularly for HSV-1 genital infections. Many people eventually stop having noticeable outbreaks altogether, though the virus remains present and can still shed asymptomatically.
Daily suppressive therapy remains optional. Some people take it continuously to reduce transmission risk or prevent outbreaks, while others take antivirals only during active episodes. The choice depends on outbreak frequency, relationship context, and personal preference. There are no significant long-term health risks from daily suppressive antiviral use; people have taken these medications safely for decades.
The honest summary: you cannot get rid of herpes today, but you can reduce its impact to the point where it plays a very small role in your daily life. The science aimed at a true cure is closer than it has ever been, with gene editing showing the most promising path forward.